Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

Multi-center, Prospective, Non-interventional, Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02946450

Enrollment

3000

Registered

2016-10-27

Start date

2014-03-31

Completion date

Unknown

Last updated

2016-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT Scanning Patients

Brief summary

The purpose of this study is to assess safety of Omnipure inj. (lohexol) contrast media in CT scanning patients

Interventions

DRUGOther: Not applicable-observational study

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* subjects in need of CT scanning * subjects who signed up informed consent

Exclusion criteria

* Known allergy or hypersensitivity to the study medication, ingredient of the medication, and Iodine type medication * severe renal insufficiency patients * severe hypothyroidism * severe local infection or bacteremia

Design outcomes

Primary

Measure	Time frame
adverse events, adverse drug reaction, serious adverse events, serious drug reaction, laboratory data, vital signs	14 days

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026